Stay updated on RMC-6236 in RAS Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page.

Latest updates to the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedThe page no longer displays the 403 error and its related breadcrumb labels. The NIH transition announcement is also gone, leaving the site navigation and footer visible.SummaryDifference3%

- Check10 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check17 days agoChange DetectedA sitewide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check24 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2; the page content remains a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedThe footer shows site revision v3.7.1 instead of v3.7.0. The page continues to display a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now displays a 403 error, replacing the usual study details and navigation with an error display. This indicates that access to the study record is blocked.SummaryDifference19%

Stay in the know with updates to RMC-6236 in RAS Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page.